Table 1

Characteristics of included person-time

  Working ageElderly
DiabetesDiabetesNo diabetes (matched controls)
VariableValueNPNPNP
Age (median, IQR)Years5313.007411.007411.00
SexMale1296380.52848950.471272110.44
Female1194730.48950200.531610760.56
Income quintileUpper1111670.45778060.431373030.48
Lower1379440.551021090.571509840.52
ResidenceUrban1457120.581081470.601732040.60
Rural1033990.42717680.401150830.40
Medical visits*01455640.58922650.511749400.61
1–2626660.25420340.23605110.21
3 or more408810.16456160.25528360.18
Major ADGs†01091070.44466300.261023470.36
1749300.30558930.31920290.32
2 or more650740.26773920.43939110.33
Influenza vaccination‡Yes862220.35964630.541391140.48
No1628890.65834520.461491730.52
Pneumococcal vaccination§Yes400200.16820840.461161780.40
No2090910.84978310.541721090.60
  • Table enumerates subjects at follow-up every July. All differences between elderly adults and working-age diabetic adults p<0.001 on Wilcoxon rank sum or χ2 tests.

  • *Number of medical visits over the previous year.

  • †Number of major ADGs over the previous 2 years: ADG3 (time limited: major), ADG4 (time limited: major—primary infections), ADG9 (likely to recur: progressive), ADG11 (chronic medical: unstable), ADG16 (chronic specialty: unstable—orthopaedic), ADG22 (injuries/adverse effects: major), ADG25 (psychosocial: recurrent or persistent, unstable) and ADG32 (malignancy).

  • ‡Influenza vaccination during the previous year.

  • §Any previous record of pneumococcal vaccination.

  • IQR, inter-quartile range; N, Number of subjects; P, Proportion of subjects.